Evidence map›Paper›PMID 29267205›Full record

ArticleBrain sciences2017

Disturbed Glucose Metabolism in Rat Neurons Exposed to Cerebrospinal Fluid Obtained from Multiple Sclerosis Subjects.

Deepali Mathur, Eva María-Lafuente, Juan R Ureña-Peralta, Lucas Sorribes, Alberto Hernández, Bonaventura Casanova, Gerardo López-Rodas, Francisco Coret-Ferrer, Maria Burgal-Marti

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Potential Biomarkers Associated with Multiple Sclerosis Pathology.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Deepali MathurDepartment of Functional Biology, University of Valencia, 46100 Valencia, Spain. matdeepali@gmail.com.
Eva María-LafuenteMultiple Sclerosis Laboratory, Department of Biomedicine, Prince Felipe Research Center, 46012 Valencia, Spain. zacapardo@gmail.com.
Juan R Ureña-PeraltaMultiple Sclerosis Laboratory, Department of Biomedicine, Prince Felipe Research Center, 46012 Valencia, Spain. jurena@cipf.es.
Lucas SorribesMultiple Sclerosis Laboratory, Department of Biomedicine, Prince Felipe Research Center, 46012 Valencia, Spain. lucas.sorribes@gmail.com.
Alberto HernándezMultiple Sclerosis Laboratory, Department of Biomedicine, Prince Felipe Research Center, 46012 Valencia, Spain. alheca73@hotmail.com.
Bonaventura CasanovaCSUR-Esclerosi Múltiple, Hospital Universitari i Politècnic La Fe, Unitat Mixta d'Esclerosi Múltiple i Neurorregeneració de l'IIS-La Fe, 46026 València, Spain. casanova.bonaventura@gmail.com.
Gerardo López-RodasDepartment of Biochemistry and Molecular Biology, University of Valencia and INCLIVA Biomedical Research Institute, 46100 Valencia, Spain. gerardo.lopez@uv.es.
Francisco Coret-FerrerHospital Clínico, Universitario de Valencia, 46010 Valencia, Spain. coretf@gmail.com.
Maria Burgal-MartiMultiple Sclerosis Laboratory, Department of Biomedicine, Prince Felipe Research Center, 46012 Valencia, Spain. mburgalmarti@icloud.com.
Centro de Investigacion Principe Felipe · ESUniversitat de València · ESHospital Clínico Universitario de Valencia · ESHospital Universitari i Politècnic La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Axonal damage is widely accepted as a major cause of permanent functional disability in Multiple Sclerosis (MS). In relapsing-remitting MS, there is a possibility of remyelination by myelin producing cells and restoration of neurological function. The purpose of this study was to delineate the pathophysiological mechanisms underpinning axonal injury through hitherto unknown factors present in cerebrospinal fluid (CSF) that may regulate axonal damage, remyelinate the axon and make functional recovery possible. We employed primary cultures of rat unmyelinated cerebellar granule neurons and treated them with CSF obtained from MS and Neuromyelitis optica (NMO) patients. We performed microarray gene expression profiling to study changes in gene expression in treated neurons as compared to controls. Additionally, we determined the influence of gene-gene interaction upon the whole metabolic network in our experimental conditions using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) program. Our findings revealed the downregulated expression of genes involved in glucose metabolism in MS-derived CSF-treated neurons and upregulated expression of genes in NMO-derived CSF-treated neurons. We conclude that factors in the CSF of these patients caused a perturbation in metabolic gene(s) expression and suggest that MS appears to be linked with metabolic deformity.

Indexed as

cerebrospinal fluidgene expressionglucose metabolismmultiple sclerosisneuromyelitis optica

Identifiers

PMID29267205
PMCPMC5789332
OpenAlexW2778645321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.